These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38010605)

  • 1. Mycobacterial FtsZ and inhibitors: a promising target for the anti-tubercular drug development.
    Shinde Y; Pathan A; Chinnam S; Rathod G; Patil B; Dhangar M; Mathew B; Kim H; Mundada A; Kukreti N; Ahmad I; Patel H
    Mol Divers; 2023 Nov; ():. PubMed ID: 38010605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of anti-TB agents that target the cell-division protein FtsZ.
    Kumar K; Awasthi D; Berger WT; Tonge PJ; Slayden RA; Ojima I
    Future Med Chem; 2010 Aug; 2(8):1305-23. PubMed ID: 21339840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FtsZ: a novel target for tuberculosis drug discovery.
    Huang Q; Tonge PJ; Slayden RA; Kirikae T; Ojima I
    Curr Top Med Chem; 2007; 7(5):527-43. PubMed ID: 17346197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
    Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
    Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of anti-tuberculosis agents that target the cell-division protein FtsZ.
    Lin Y; Zhu N; Han Y; Jiang J; Si S
    J Antibiot (Tokyo); 2014 Sep; 67(9):671-6. PubMed ID: 24984796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of anti-
    Zhang H; Chen Y; Zhang Y; Qiao L; Chi X; Han Y; Lin Y; Si S; Jiang J
    Acta Pharm Sin B; 2023 May; 13(5):2056-2070. PubMed ID: 37250168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.
    Mitra K; Chadha A; Doble M
    Eur J Pharm Sci; 2019 Jul; 135():103-112. PubMed ID: 31034983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings.
    Chauhan A; Madiraju MV; Fol M; Lofton H; Maloney E; Reynolds R; Rajagopalan M
    J Bacteriol; 2006 Mar; 188(5):1856-65. PubMed ID: 16484196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target.
    Ur Rahman M; Wang P; Wang N; Chen Y
    Bosn J Basic Med Sci; 2020 Aug; 20(3):310-318. PubMed ID: 32020845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.
    Margalit DN; Romberg L; Mets RB; Hebert AM; Mitchison TJ; Kirschner MW; RayChaudhuri D
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11821-6. PubMed ID: 15289600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
    Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
    J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress of bacterial FtsZ inhibitors with a focus on peptides.
    Han H; Wang Z; Li T; Teng D; Mao R; Hao Y; Yang N; Wang X; Wang J
    FEBS J; 2021 Feb; 288(4):1091-1106. PubMed ID: 32681661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors.
    Khadkikar P; Goud NS; Mohammed A; Ramamoorthy G; Ananthathatmula R; Doble M; Rizvi A; Banerjee S; Ravi A; Alvala M
    Chem Biol Drug Des; 2018 Dec; 92(6):1933-1939. PubMed ID: 30003661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Bacterial Division Protein FtsZ.
    Hurley KA; Santos TM; Nepomuceno GM; Huynh V; Shaw JT; Weibel DB
    J Med Chem; 2016 Aug; 59(15):6975-98. PubMed ID: 26756351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role of phosphorylation-dependent interaction between FtsZ and FipA in mycobacterial cell division.
    Sureka K; Hossain T; Mukherjee P; Chatterjee P; Datta P; Kundu M; Basu J
    PLoS One; 2010 Jan; 5(1):e8590. PubMed ID: 20066037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization.
    Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
    J Biomol Struct Dyn; 2022 Mar; 40(4):1558-1570. PubMed ID: 33021149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
    Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
    Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
    Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
    J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.